14 results match your criteria: "The National Addiction Centre[Affiliation]"
J Addict Med
October 2024
From the National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, United Kingdom and South London, and the Maudsley NHS Foundation Trust, United Kingdom (ER); and South London and the Maudsley NHS Foundation Trust, United Kingdom (ES, IG).
Objectives: There has been limited evidence synthesis examining treatment of ketamine use disorder. We aimed to conduct a systematic review to assess the efficacy and tolerability of pharmacological interventions in the management of ketamine use disorder.
Methods: We searched MEDLINE, EMBASE, PsychINFO, and CENTRAL (Cochrane Central Register of Controlled Trials) from database inception to November 14, 2023, for studies of any design that reported on any pharmacological intervention in the management of ketamine use disorder.
Addiction
September 2019
Centre for Youth Substance Abuse Research, The University of Queensland and the National Addiction Centre, King's College, London.
Addiction
November 2019
King's College London, The National Addiction Centre, London, UK.
Background/aims: Contingency management (CM) interventions have gained considerable interest due to their success in the treatment of addiction. However, their implementation can be resource-intensive for clinical staff. Mobile telephone-based systems might offer a low-cost alternative.
View Article and Find Full Text PDFAddiction
February 2019
The Centre for Youth Substance Abuse Research, The University of Queensland and the National Addiction Centre, King's College London, London, UK.
Lancet
April 2018
The University of Queensland Centre for Youth Substance Abuse Research, The University of Queensland, St Lucia, QLD, Australia; The National Addiction Centre, King's College London, London, UK. Electronic address:
Lancet Psychiatry
April 2017
John Strang Centre for Youth Substance Abuse Research, University of Queensland, QLD 4029, Australia; The National Addiction Centre, Kings College London, London, UK.
Lancet Psychiatry
July 2015
Christchurch Health and Development Study, University of Otago, Christchurch, New Zealand.
Addiction
July 2015
The University of Queensland Centre for Clinical Research, Herston, Australia.
Background: Some countries have banned the sale of electronic nicotine delivery systems (ENDS).
Aims: We analyse the ethical issues raised by this ban and various ways in which the sale of ENDS could be permitted.
Method: We examine the ban and alternative policies in terms of the degree to which they respect ethical principles of autonomy, beneficence, non-maleficence and justice, as follows.
Addiction
January 2015
The University of Queensland Centre for Youth Substance Abuse Research and The UQ Centre for Clinical Research, Herston, Australia; The National Addiction Centre, Kings College London, London, UK; National Drug and Alcohol Research Centre, University of New South Wales, New South Wales, Australia.
Aims: To examine changes in the evidence on the adverse health effects of cannabis since 1993.
Methods: A comparison of the evidence in 1993 with the evidence and interpretation of the same health outcomes in 2013.
Results: Research in the past 20 years has shown that driving while cannabis-impaired approximately doubles car crash risk and that around one in 10 regular cannabis users develop dependence.
Lancet Respir Med
August 2014
The University of Queensland Centre for Clinical Research, QLD 4029, Australia.
The efficacy of lofexidine/naloxone was compared with lofexidine/placebo in a double-blind, randomized, placebo-controlled trial in 89 opiate-dependent patients. There were no significant differences between the two groups in the proportion of patients completing detoxification or in the length of stay. Patients in the active naloxone group demonstrated gradual reductions in levels of withdrawal and craving over the detoxification period.
View Article and Find Full Text PDFAims: To compare National Health Service (NHS) and private practice in prescribing methadone to opiate addicts.
Design And Participants: Survey of community pharmacies during 1995 (one in four random sample) and during 1997 (one in two random sample) in which data were collected on all methadone prescriptions currently being dispensed to opiate addicts.
Setting: Dispensing community pharmacies in south east England.
Eur J Clin Microbiol Infect Dis
November 2000
The National Addiction Centre, Institute of Psychiatry/Maudsley Hospital, London, UK.
Since viral hepatitis among intravenous drug users continues to be a major cause of morbidity and mortality, the present study was conducted to survey drug agencies in England and Wales in order to identify the prevalence of hepatitis B and C testing and vaccination being provided. A postal survey of all 539 drug agencies in England and Wales was thus conducted to assess their current treatment provisions and practices. An analysis of the responses provided by the 373 agencies that returned usable data (69.
View Article and Find Full Text PDFDrug Alcohol Rev
March 1997
The National Addiction Centre, the Maudsley/Institute of Psychiatry, London, UK.
Prescribing heroin in the treatment of addiction has been, until recently, an exclusively UK practice. However, despite international fascination with such prescribing, no recent report exists on the extent or nature of the practice. Furthermore, no data have ever previously been available on dispensing arrangements and geographical localization of heroin-prescribing to addicts.
View Article and Find Full Text PDF